DRC Ebola Outbreak Shows Early Improvement, But WHO Warns of Prolonged Fight

By Hannah Yemisi

The Democratic Republic of Congo (DRC)’s Ebola outbreak is showing early signs of improvement in some affected areas, but the World Health Organization (WHO) says transmission remains active and the epidemic continues to claim lives.

DEVELOPMENT:

Director-General (DG) of WHO, Tedros Adhanom Ghebreyesus, said that on Wednesday that health authorities were beginning to see evidence that the response was gaining ground following the declaration of the DRC’s 17th Ebola outbreak in mid-May.

“We are starting to see encouraging signs that we’re gaining ground,” Tedros told a news conference in Geneva.

He said that transmission was declining in Ituri province, the epicentre of the outbreak, while South Kivu has recorded no new cases since May.

Tedros also said treatment and post-exposure prophylaxis trials were accelerating, supported by increased community engagement.

“Trials of treatments and post-exposure prophylaxis are picking up speed, due to increased community engagement,” he said.

Vaccine trials are expected to begin in the coming weeks.

However, Tedros cautioned against interpreting the latest improvements as the end of the outbreak.

“Make no mistake: the epidemic continues to grow and continues to kill,” he also said.

DATA:

Since the outbreak was declared in May, more than 7,200 cases and 3,500 deaths have reportedly been recorded across seven provinces in northern and eastern DRC.

Ebola is transmitted through contact with infected bodily fluids and can cause severe illness, including internal and external bleeding and organ failure.

More than 15,000 people have died from Ebola in Africa over the past 50 years.

SIGNIFICANCE:

The mixed picture highlights the difficulty of controlling infectious disease outbreaks in areas affected by insecurity and armed conflict.

Declining transmission in Ituri and the absence of new cases in South Kivu indicate that response measures may be producing results in some locations. However, continued transmission elsewhere means the overall outbreak remains a significant public-health challenge.

The acceleration of treatment, prophylaxis and vaccine trials also introduces an important research dimension, potentially strengthening the tools available to control Ebola.

NEXT MOVE:

The immediate indicators are new case numbers, deaths, transmission patterns across affected provinces, progress in treatment and prophylaxis trials, and the commencement of vaccine trials.

Community engagement will also remain critical to surveillance, contact tracing and treatment uptake.

OUR LENS:

The DRC outbreak illustrates the difference between localised progress and epidemic-wide control. Improvements in Ituri and South Kivu provide evidence that containment is possible, but they do not yet establish a sustained national decline.

Maria Van Kerkhove, Director of Epidemic and Pandemic Management at WHO, reinforced the scale of the challenge.

“We still have many, many months ahead of us,” she said.

For health systems and international responders, the deeper requirement is therefore sustained surveillance, community cooperation, clinical research and vaccination capacity until transmission is consistently brought under control.

Hannah Yemisi is a reporter of note, reporting on education, business, economic and social developments with a focus on accuracy, context and public relevance.